$2.27 Billion is the total value of Graham Capital Management, L.P.'s 65 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TESLA INCnote | $100,086,000 | +18.7% | 82,400,000 | 0.0% | 4.41% | +151.3% | ||
| AK STL CORPnote | $67,327,000 | -14.5% | 67,889,000 | 0.0% | 2.97% | +80.9% | ||
| SILVER STD RES INCnote | $35,772,000 | +0.8% | 35,968,000 | 0.0% | 1.58% | +113.6% | ||
| GOPRO INCnote | $24,725,000 | -13.9% | 30,000,000 | 0.0% | 1.09% | +82.3% | ||
| PRETIUM RES INCnote | $18,004,000 | +0.7% | 20,000,000 | 0.0% | 0.79% | +113.2% | ||
| INTREXON CORPnote | $16,339,000 | -39.6% | 23,000,000 | 0.0% | 0.72% | +27.9% | ||
| CANADIAN SOLAR INCnote | $15,786,000 | +0.2% | 16,000,000 | 0.0% | 0.70% | +112.2% | ||
| RTW HLDGS INCnote | $14,866,000 | -0.6% | 14,750,000 | 0.0% | 0.66% | +110.6% | ||
| KAMAN CORPnote | $13,669,000 | -9.5% | 12,875,000 | 0.0% | 0.60% | +91.7% | ||
| RADIUS HEALTH INCnote | $13,497,000 | +0.4% | 17,500,000 | 0.0% | 0.60% | +112.5% | ||
| INTERCEPT PHARMACEUTICALS INnote | $13,509,000 | -8.5% | 14,636,000 | 0.0% | 0.60% | +93.8% | ||
| ARRAY BIOPHARMA INCnote | $12,170,000 | -3.4% | 10,000,000 | 0.0% | 0.54% | +104.6% | ||
| SHIP FIN INTL LTDnote | $11,741,000 | -9.6% | 13,000,000 | 0.0% | 0.52% | +91.5% | ||
| GOLAR LNG LTDnote | $8,286,000 | -11.0% | 8,900,000 | 0.0% | 0.36% | +88.1% | ||
| SUNPOWER CORPdbcv 4.000% 1/1 | $7,042,000 | -6.8% | 9,000,000 | 0.0% | 0.31% | +97.5% | ||
| DERMIRA INCnote | $6,582,000 | -7.3% | 8,500,000 | 0.0% | 0.29% | +95.9% | ||
| ENCORE CAP EUROPE FIN LTDnote | $6,063,000 | -21.3% | 7,500,000 | 0.0% | 0.27% | +66.9% | ||
| CME | CME GROUP INC | $5,643,000 | +10.5% | 30,000 | 0.0% | 0.25% | +134.9% | |
| PANDORA MEDIA INCnote | $4,036,000 | -2.5% | 4,250,000 | 0.0% | 0.18% | +107.0% | ||
| SUNPOWER CORPdbcv 0.875% 6/0 | $3,752,000 | -7.2% | 4,936,000 | 0.0% | 0.16% | +96.4% | ||
| XON | INTREXON CORP | $789,000 | -62.0% | 120,700 | 0.0% | 0.04% | -18.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CME GROUP INC | 42 | Q3 2023 | 0.8% |
| ISHARES TR | 27 | Q3 2023 | 20.0% |
| SELECT SECTOR SPDR TR | 27 | Q4 2022 | 7.4% |
| SELECT SECTOR SPDR TR | 27 | Q2 2022 | 2.9% |
| MICROSOFT CORP | 25 | Q3 2023 | 1.5% |
| JPMORGAN CHASE & CO | 23 | Q3 2023 | 1.4% |
| SPDR GOLD TRUST | 22 | Q4 2020 | 53.4% |
| ISHARES TR | 22 | Q1 2023 | 3.1% |
| ISHARES INC | 21 | Q2 2023 | 4.0% |
| OPKO HEALTH INC | 19 | Q3 2023 | 3.0% |
View Graham Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-22 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Graham Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.